Outcomes of MCS as a Bridge to Heart Transplantation: Are We Compromising Shortand Long-term Outcomes?

Heart transplantation provides remarkable improvement. Transplantation

Transplantation Morbidity and Mortality in Heart Transplant Candidates Supported With Mechanical Circulatory Support Is Reappraisal of the Current United Network for Organ Sharing Thoracic Organ Allocation

Mechanical assist patient selection, device selection, and outcomes

Mechanical assist patient selection, device selection, and outcomes Josef Stehlik, MD, MPH Associate Professor of Medicine Medical Director, Heart Transplant Program University of Utah School of Medicine

Mechanical Circulatory Support in the Management of Heart Failure

Mechanical Circulatory Support in the Management of Heart Failure Feras Bader, MD, MS, FACC Associate Professor of Medicine Director, Heart Failure and Transplant Cleveland Clinic Abu Dhabi Chairman, Heart

Ramani GV et al. Mayo Clin Proc 2010;85:180-95

THERAPIES FOR ADVANCED HEART FAILURE: WHEN TO REFER Navin Rajagopalan, MD Assistant Professor of Medicine University of Kentucky Director, Congestive Heart Failure Medical Director of Cardiac Transplantation

ECMO as a Bridge to Heart Transplant in the Era of LVAD s.

Christian Bermudez MD. Associate Professor Director Thoracic Transplantation Division Cardiac Surgery Department of Surgery University of Pennsylvania ECMO as a Bridge to Heart Transplant in the Era of

Recent Trials With Durable LVADs: Is There a Superior Device?

Recent Trials With Durable LVADs: Is There a Superior Device? Francis D. Pagani MD PhD Otto Gago MD Endowed Professor of Cardiac Surgery Michigan Medicine Current Device Landscape 2018 HeartMate 3 HeartMate

Translating Device and Mechanical Support Guidelines to ACHD Research. Timothy M. Maul, CCP, PhD Perfusionist Sr. Research Scientist

Translating Device and Mechanical Support Guidelines to ACHD Research Timothy M. Maul, CCP, PhD Perfusionist Sr. Research Scientist Disclosures No financial disclosures May discuss off-label or investigational

Destination Life in Japan and the United States: A new lifestyle for heart failure patients with left ventricular assist devices

Michael Yamakawa 1 Destination Life in Japan and the United States: A new lifestyle for heart failure patients with left ventricular assist devices Michael Yamakawa Biophysics Johns Hopkins University

Concomitant Aortic Valve Procedures in Patients Undergoing Implantation of Continuous-Flow LVADs: An INTERMACS Database Analysis

Concomitant Aortic Valve Procedures in Patients Undergoing Implantation of Continuous-Flow LVADs: An INTERMACS Database Analysis April 11, 2014 Jason O. Robertson, M.D., M.S.; David C. Naftel, Ph.D., Sunil

Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: the EUROMACS-RHF Risk Score Osama I.I. Soliman, MD, PhD, FACC,

Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3) Long Term Outcomes

Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with (MOMENTUM 3) Long Term Outcomes Mandeep R. Mehra, MD, Daniel J. Goldstein, MD, Nir Uriel, MD, Joseph

HEARTMATE II LEFT VENTRICULAR ASSIST SYSTEM. HeartMate II Left Ventricular Assist Device

HEARTMATE II LEFT VENTRICULAR ASSIST SYSTEM HeartMate II Left Ventricular Assist Device HeartMate II Left Ventricular Assist Device UNPARALLELED REAL-WORLD EXPERIENCE Over 25,000 heart failure patients

Journal Watch. April. REVIEW: Donor-recipient matching in heart transplantation HEART FAILURE AND TRANSPLANTATION

Journal Watch April 2018 Philipp Angleitner, MD Medical University of Vienna Vienna, Austria philipp.angleitner@meduniwien.ac.at Andreas Zuckermann, MD, PhD Medical University of Vienna Vienna, Austria

End-Stage Heart Failure Heart Transplantation Mechanical Circulatory Support

Greek International Experience End-Stage Heart Failure Heart Transplantation Mechanical Circulatory Support Stamatis Adamopoulos, MD, PhD (Imperial College) Heart Failure-Transplant Unit Onassis Cardiac

Right Heart Failure in LVAD patients: Prevention and Management.

Christian Bermudez MD. Associate Professor Director Thoracic Transplantation Division Cardiac Surgery Department of Surgery University of Pennsylvania Right Heart Failure in LVAD patients: Prevention and

Ventricular Assist Devices for Permanent Therapy: Current Status and Future

Ventricular Assist Devices for Permanent Therapy: Current Status and Future Prospects Francis D. Pagani MD PhD Professor of Cardiac Surgery University of Michigan April 28 th, 2012 Disclosures NHLBI and

Do we really need an Artificial Heart? No!! John V. Conte, MD, Professor of Surgery Johns Hopkins University School of Medicine

Do we really need an Artificial Heart? No!! John V. Conte, MD, Professor of Surgery Johns Hopkins University School of Medicine Division of Cardiac Surgery The Johns Hopkins Medical Institutions Conflict

Andrew Civitello MD, FACC

Timing the Transition from Short Term to Long Term Mechanical Circulatory Support Andrew Civitello MD, FACC Medical Director, Heart Transplant Program Director, Fellowship Co-Director, Baylor St. Luke's

Risk Factors for Adverse Outcome after HeartMate II Jennifer Cowger, MD, MS St. Vincent Heart Center of Indiana

Risk Factors for Adverse Outcome after HeartMate II Jennifer Cowger, MD, MS St. Vincent Heart Center of Indiana Advanced Heart Failure, Transplant, & Mechanical Circulatory Support Relevant Financial Relationship

VAD Mechanical Circulatory Support in ACHD as a Bridge to Recovery/Transplant or Destination Therapy

VAD Mechanical Circulatory Support in ACHD as a Bridge to Recovery/Transplant or Destination Therapy David N. Campbell MD Professor of Surgery, UC, Denver and the Children s Hospital Colorado Surgical

เอกราช อร ยะช ยพาณ ชย

30 July 2016 เอกราช อร ยะช ยพาณ ชย Heart Failure and Transplant Cardiology aekarach.a@chula.ac.th Disclosure Speaker, CME service: Merck, Otsuka, Servier Consultant, non-cme service: Novartis, Menarini

Update on Mechanical Circulatory Support. AATS May 5, 2010 Toronto, ON Canada

Update on Mechanical Circulatory Support AATS May 5, 2010 Toronto, ON Canada Disclosures NONE Emergency Circulatory Support ECMO Tandem Heart Impella Assessment Cardiac Function Pulmonary function Valvular

Ventricular Assist Devices for Chronic Heart Failure

Ventricular Assist Devices for Chronic Heart Failure Σ.Γ.Δράκος, Επικ. Καθ/τής Medical Director, Cardiac Mechanical Support Program Investigator, Molecular Medicine Program University of Utah Heart Failure:

Seventh INTERMACS annual report: 15,000 patients and counting

http://www.jhltonline.org INTERMACS ANNUAL REPORT Seventh INTERMACS annual report: 15,000 patients and counting James K. Kirklin, MD, a David C. Naftel, PhD, a Francis D. Pagani, MD, PhD, b Robert L. Kormos,

Thoracic Simulation Allocation Modeling (TSAM) of a 6-Tier Allocation Strategy for Heart Transplant

Thoracic Simulation Allocation Modeling (TSAM) of a 6-Tier Allocation Strategy for Heart Transplant Monica Colvin, Melissa Skeans, Liz Robbins, Leah Edwards, Jessica Zeglin, Scott Silvestry, Ryan Davies,

Why Children Are Not Small Adults? Treatment of Pediatric Patients Needing Mechanical Circulatory Support

Why Children Are Not Small Adults? Treatment of Pediatric Patients Needing Mechanical Circulatory Support Utpal S Bhalala, MD, FAAP Assistant Professor and Director of Research Pediatric Critical Care

Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients

http://www.jhltonline.org SPECIAL FEATURE Fifth INTERMACS annual report: Risk factor analysis from more than 6, mechanical circulatory support patients James K. Kirklin, MD, a David C. Naftel, PhD, a Robert

When to implant VAD in patients with heart transplantation indication. Aldo Cannata Dept of Cardiac Surgery Niguarda Ca Granda Hospital Milano

When to implant VAD in patients with heart transplantation indication Aldo Cannata Dept of Cardiac Surgery Niguarda Ca Granda Hospital Milano LVAD strategies In waiting list? Goal Bridge to transplant

What has INTERMACS Taught Us about Patient Outcomes with Durable MCS? James K. Kirklin, MD

What has INTERMACS Taught Us about Patient Outcomes with Durable MCS? James K. Kirklin, MD Disclosure: I am Director of the Data Coordinating Center for the INTERMACS project and receive support through

Pediatric Mechanical Circulatory Support (MCS)

Pediatric Mechanical Circulatory Support (MCS) Ivan Wilmot, MD Heart Failure, Transplant, MCS Assistant Professor The Heart Institute Cincinnati Children s Hospital Medical Center The University of Cincinnati

Ventricular Assist Device: Are Early Interventions Superior? Hamang Patel, MD Section of Cardiomyopathy & Heart Transplantation

Ventricular Assist Device: Are Early Interventions Superior? Hamang Patel, MD Section of Cardiomyopathy & Heart Transplantation Objectives Current rationale behind use of MCS Patient Selection Earlier?

Overview of MCS in Bruce B Reid, MD Surgical Director Artificial Heart Program/Heart Transplantation

Overview of MCS in 2017 Bruce B Reid, MD Surgical Director Artificial Heart Program/Heart Transplantation Technology Embracing Progress Technology Adoption Internet Adoption of Technology Pioneer in the

Medical Therapy after LVAD

Medical Therapy after LVAD Maria Frigerio 2nd Section of Cardiology, Heart Failure & Cardiac Transplant Unit DeGasperis CardioCenter, Niguarda Hospital, Milan, Italy Heart failure therapy in LVAD pts A

A Fully Magnetically Levitated Left Ventricular Assist Device. Final Report of the MOMENTUM 3 Trial

A Fully Magnetically Levitated Left Ventricular Assist Device Final Report of the MOMENTUM 3 Trial Mandeep R. Mehra, MD, Nir Uriel, MD, Joseph C. Cleveland, Jr., MD, Daniel J. Goldstein, MD, National Principal

HFA- ESC criteria for Advanced HF and US Requirements for Destination Therapy

HFA- ESC criteria for Advanced HF and US Requirements for Destination Therapy ESC- HFA criteria for Adv-HF Severe symptoms of HF (NYHA class III or IV) with episodes of fluid retention and/or peripheral

Lessons learned from ENDURANCE, ROADMAP, MedaMACS, and how to go forward?

Lessons learned from ENDURANCE, ROADMAP, MedaMACS, and how to go forward? Mark S. Slaughter, MD Professor and Chair Department of Cardiovascular and Thoracic Surgery University of Louisville What could

LVAD Complications, Recovery

LVAD Complications, Recovery Abbas Ardehali, M.D., F.A.C.S. Professor of Surgery and Medicine, Division of Cardiac Surgery William E. Connor Chair in Cardiothoracic Transplantation Director, UCLA Heart,

ISHLT ACADEMY MASTER CLASS IN MECHANICAL CIRCULATORY SUPPORT (MCS)

ISHLT ACADEMY MASTER CLASS IN MECHANICAL CIRCULATORY SUPPORT (MCS) Saturday, April 30, 2016 1:45 PM 6:30 PM Marriott Wardman Park Hotel, Washington, DC, USA WASHINGTON BALLROOMS 1 & 2 ISHLT ACADEMY MASTER

Heart Transplantation & MCS in 2017 Advances & Challenges

Heart Transplantation & MCS in 2017 Advances & Challenges Steven Tsui Papworth Hospital, Cambridge, UK Papworth Hospital Heart Transplantation ADVANCES AND CHALLENGES Heart Transplants 100 75 Adult Heart

Right Ventricular Failure: Prediction, Prevention and Treatment

Right Ventricular Failure: Prediction, Prevention and Treatment 3 rd European Training Symposium for Heart Failure Cardiologists and Cardiac Surgeons University Hospital Bern June 24-25, 2016 Disclosures:

Donor/Recipient Risk Scores: Review of Published Approaches from Europe and the US

Donor/Recipient Risk Scores: Review of Published Approaches from Europe and the US Michael M. Givertz, MD Medical Director, Heart Transplant and MCS Brigham and Women s Hospital Professor of Medicine,

Extracorporeal life support in preoperative and postoperative heart transplant management

Review Article Page 1 of 6 Extracorporeal life support in preoperative and postoperative heart transplant management Christian A. Bermudez 1, D. Michael McMullan 2 1 Division of Cardiovascular Surgery,

LEFT VENTRICULAR ASSIST DEVICE COMPLICATIONS. Daniel Vargas, MD Section of Cardiothoracic Imaging University of Colorado Anschutz Medical Campus

LEFT VENTRICULAR ASSIST DEVICE COMPLICATIONS Daniel Vargas, MD Section of Cardiothoracic Imaging University of Colorado Anschutz Medical Campus OBJECTIVES Review the most common LVAD-related complications.

Predicting Major Outcomes after MCSD Implant. Risk Factors for Death, Transplant, and Recovery. James Kirklin, MD David Naftel, PhD

Predicting Major Outcomes after MCSD Implant Risk Factors for Death, Transplant, and Recovery James Kirklin, MD David Naftel, PhD 1 I have no financial disclosures (I am the Principle Investigator for

Left Ventricular Assist Devices (LVADs): Overview and Future Directions

Left Ventricular Assist Devices (LVADs): Overview and Future Directions FATIMA KARAKI, M.D. PGY-3, DEPARTMENT OF MEDICINE WASHINGTON UNIVERSITY IN ST. LOUIS ST. LOUIS, MISSOURI, USA St. Louis, Missouri,

Effect of ABO-Incompatible Listing on Infant Heart Transplant Waitlist Outcomes: Analysis of the United Network for Organ Sharing (UNOS) Database

FEATURED ARTICLES Effect of ABO-Incompatible Listing on Infant Heart Transplant Waitlist Outcomes: Analysis of the United Network for Organ Sharing (UNOS) Database Melanie D. Everitt, MD, a,b,c Amy E.

Minimally invasive is the future of left ventricular assist device implantation

Review Article Minimally invasive is the future of left ventricular assist device implantation George Makdisi, I-Wen Wang Indiana University School of Medicine & Indiana University Health, Indianapolis,

Total Artificial Hearts and Implantable Ventricular Assist Devices

Total Artificial Hearts and Implantable Ventricular Assist Devices Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively

Outcome of heart transplantation after bridge-to-transplant strategy using various mechanical circulatory support devices

Interactive CardioVascular and Thoracic Surgery 25 (2017) 918 924 doi:10.1093/icvts/ivx201 Advance Access publication 4 July 2017 ORIGINAL ARTICLE Cite this article as: Yoshioka D, Li B, Takayama H, Garan

LVADs as Destination Therapy: When Best Practice Criteria Meets the Real World

LVADs as Destination Therapy: When Best Practice Criteria Meets the Real World Farooq Sheikh, M.D., FACC Advanced Heart Failure Program MedStar Washington Hospital Center Disclosure I have no relevant

How to Develop a Comprehensive Ventricular Assist Device Program

How to Develop a Comprehensive Ventricular Assist Device Program Rodrigo V. González, MD, MS Sección de Cirugía Cardiovascular División de Cirugía Facultad de Medicina Pontificia Universidad Católica de

ORIGINAL ARTICLE. Alexander M. Bernhardt a, *, Theo M.M.H. De By b, Hermann Reichenspurner a and Tobias Deuse a. Abstract INTRODUCTION

European Journal of Cardio-Thoracic Surgery 48 (2015) 158 162 doi:10.1093/ejcts/ezu406 Advance Access publication 29 October 2014 ORIGINAL ARTICLE Cite this article as: Bernhardt AM, De By TMMH, Reichenspurner

ECMO AND SHORT-TERM SUPPORT:

ECMO AND SHORT-TERM SUPPORT: UTILIZATION GUIDELINES AND IMPACT OF THE NEW HEART ALLOCATION SYSTEM Jeffrey Teuteberg Section Chief of Heart Failure, Cardiac Transplant and Mechanical Circulatory Support

Sixth INTERMACS annual report: A 10,000-patient database

http://www.jhltonline.org INTERMACS ANNUAL FEATURE Sixth INTERMACS annu report: A 10,000-patient database James K. Kirklin, MD, a David C. Naftel, PhD, a Francis D. Pagani, MD, PhD, b Robert L. Kormos,

Acute Circulatory Support Should We or Shouldn t We?

Acute Circulatory Support Should We or Shouldn t We? Navin K. Kapur, MD, FACC, FSCAI Assistant Professor, Division of Cardiology Director, Acute Circulatory Support Program Director, Interventional Research

Journal of the American College of Cardiology Vol. 60, No. 1, by the American College of Cardiology Foundation ISSN /$36.

Journal of the American College of Cardiology Vol. 60, No. 1, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.02.031

INTERMACS Ninth Annual Meeting Program

INTERMACS Ninth Annual Meeting Program MCSDs in 2015: Evolution, Expansion, and Evaluation Friday, May 15 2015 and Saturday, May 16 2015 Research Data Workshop Space limited Contact Grant Studdard at gkst@uab.edu

Predicting Outcomes in LVAD Recipients

Predicting Outcomes in LVAD Recipients Sean P. Pinney, MD Director, Advanced Heart Failure & Cardiac Transplantation Professor of Medicine, Cardiology Icahn School of Medicine at Mount Sinai New York,

The Effect of Ventricular Assist Devices on Post-Transplant Mortality

Journal of the American College of Cardiology Vol. 53, No. 3, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.08.070

A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD

A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD SK Singh MD MSc, DK Pujara MBBS, J Anand MD, WE Cohn MD, OH Frazier MD, HR Mallidi MD Division of Transplant & Assist

Disclosures. No disclosures to report

Disclosures No disclosures to report Update on MOMENTUM 3 Trial: The Final Word? Francis D. Pagani MD PhD Otto Gago MD Professor of Cardiac Surgery University of Michigan Ann Arbor, Michigan, USA LVAD

Readmissions: an unavoidable nemesis

Readmissions: an unavoidable nemesis This presentation was presented at the Thoratec Corporation Economic Summit held on September 30-October 2 in La Jolla, CA. Please note that this presentation and content

Multiple case reports of successful use, with only one case report of intra device thrombotic event

rfviia in VAD Patients Limited data exist regarding safety Multiple factors increase pro thrombotic potential Multiple case reports of successful use, with only one case report of intra device thrombotic

Introduction to Acute Mechanical Circulatory Support

Introduction to Acute Mechanical Circulatory Support Navin K. Kapur, MD, FACC, FSCAI, FAHA Associate Professor, Department of Medicine Interventional Cardiology & Advanced Heart Failure Programs Executive

Protocol. Total Artificial Hearts and Implantable Ventricular Assist Devices

Protocol Total Artificial Hearts and Implantable Ventricular Assist Devices (70311) Medical Benefit Effective Date: 07/01/13 Next Review Date: 05/15 Preauthorization Yes Review Dates: 01/10, 01/11, 01/12,

Bridge to Heart Transplantation

Bridge to Heart Transplantation Ulf Kjellman MD, PhD Senior Consultant Surgeon Heart Centre KFSH&RC 1 Disclosure Appointed for Proctorship by Thoratec/St.Jude/Abbott 2 To run a full overall covering transplant

MEDICAL POLICY SUBJECT: VENTRICULAR ASSIST DEVICES

MEDICAL POLICY PAGE: 1 OF: 7 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.

Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist

Dr Stephen Pettit, Consultant Cardiologist Cardiogenic shock Management of Cardiogenic Shock Outline Definition, INTERMACS classification Medical management of cardiogenic shock PA catheters and haemodynamic

Forum on U.S. Heart Allocation Policy

Forum on U.S. Heart Allocation Policy Friday, November 15 th, 2013 Dallas Marriott City Center Dallas, Texas Conference Chair: Jon Kobashigawa, MD Conference Co-Chairs: Maryl Johnson, MD Joseph Rogers,

Challenges to MCS Use in the Middle East

Challenges to MCS Use in the Middle East Feras Khaliel, MD, Ph.D Consultant Cardiac Surgeon Associate Professor of Surgery, Alfaisal Univerisity King Faisal Specialist Hospital & Research Center Dr. Michael

Mechanical Cardiac Support in Acute Heart Failure. Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research

Mechanical Cardiac Support in Acute Heart Failure Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research Disclosures Research Support and/or Consulting NHLBI Amgen Cytokinetics

LVADS IN AMBULATORY PATIENTS CLASS III PATIENT SHOULD UNDERGO LVAD IMPLANTATION

LVADS IN AMBULATORY PATIENTS CLASS III PATIENT SHOULD UNDERGO LVAD IMPLANTATION Ajith Nair MD Baylor College of Medicine / Texas Heart Institute American Association for Thoracic Surgery Mechanical Circulatory

A thesis submitted to the. Graduate School. of the University of Cincinnati. in partial fulfillment of the. requirements for the degree of

Virtual Implantation Of Mechanical Circulatory Support Devices A thesis submitted to the Graduate School of the University of Cincinnati in partial fulfillment of the requirements for the degree of Master

End-Stage Heart Failure: Heart Transplantation Mechanical Circulatory Support. Greek International Experience

End-Stage Heart Failure: Heart Transplantation Mechanical Circulatory Support Greek International Experience Stamatis Adamopoulos, MD, PhD (Imperial College) Heart Failure-Transplant Unit Onassis Cardiac

Meyer, D; et al. The Future Direction of the Adult Heart Allocation System in the United States. Am J Transplant 2015; Jan 15(1):

January Journal Watch 2015 Burhan Mohamedali, MD Rush University Chicago, Illinois, USA Burhan.mohamedali@gmail.com Rajeev Mohan, MD Scripps Clinic and Green Hospital La Jolla, California, USA Mohan.Rajeev@scrippshealth.org

Pediatric Mechanical Circulatory Support - What to Use

Pediatric Mechanical Circulatory Support - What to Use Ronald K. Woods, MD, PhD Associate Professor Medical College of Wisconsin Pediatric Cardiothoracic Surgery Children s Hospital of Wisconsin Disclosure

Ventricular Assist Devices and Total Artificial Hearts

Medical Policy Manual Surgery, Policy No. 52 Ventricular Assist Devices and Total Artificial Hearts Next Review: December 2018 Last Review: January 2018 Effective: February 1, 2018 IMPORTANT REMINDER Medical

Survival analysis and postoperative complications after ventricular assist device implantation; prognostic value of INTERMACS scale.

Research Article http://www.alliedacademies.org/annals-of-cardiovascular-and-thoracic-surgery/ Survival analysis and postoperative complications after ventricular assist device implantation; prognostic

3/23/2018. Complications of VAD Therapy: Arrhythmias. Disclosures. Agenda. I have no relevant disclosures

March 23, 2018 Complications of VAD Therapy: Arrhythmias Sandeep M. Jani, MD, MPH Associate Directory of Advanced Heart Failure and Population Health MedStar Heart and Vascular Institute - Baltimore Sandeep

Total Artificial Hearts and Implantable Ventricular Assist Devices

Total Artificial Hearts and Implantable Ventricular Assist Devices Policy Number: 7.03.11 Last Review: 12/2017 Origination: 12/2001 Next Review: 12/2018 Policy Blue Cross and Blue Shield of Kansas City

MCSD Pump Thrombosis : Industry Perspective

MCSD Pump Thrombosis : Industry Perspective John B. O Connell MD Vice President, Medical Affairs Thoratec Corporation 1 1 Thoratec Asia Pacific Mechanical Circulatory Support (MCS) Conference Agenda 15-17

Description. Section: Surgery Effective Date: January 15, 2015 Subsection: Transplant Original Policy Date: September 13, 2012 Subject:

Last Review Status/Date: December 2014 Page: 1 of 26 Description Mechanical devices to assist or replace a failing heart have been developed over many decades of research. A ventricular assist device (VAD)

End Stage Heart Failure - Time to Bring the Hammer Down

End Stage Heart Failure - Time to Bring the Hammer Down Eric R. Skipper, MD, FACS Chief, Adult Cardiovascular Surgery Surgical Director of Cardiac Transplantation and Mechanical Circulatory Support 2 3

LIVING A MORE ACTIVE LIFE. with the HeartMate 3 LVAD for the treatment of advanced heart failure RON. Recipient

LIVING A MORE ACTIVE LIFE with the HeartMate 3 LVAD for the treatment of advanced heart failure RON HeartMate 3 LVAD Recipient What is HEART FAILURE? Heart failure sometimes called a weak heart occurs

Modern Left Ventricular Assist Devices (LVAD) : An Intro, Complications, and Emergencies

Modern Left Ventricular Assist Devices (LVAD) : An Intro, Complications, and Emergencies ERIC T. ROME D.O. HEART FAILURE, MECHANICAL ASSISTANCE AND TRANSPLANTATION CVI Left Ventricular Assist Device An

Septuagenarians Bridged to Heart Transplantation With a Ventricular Assist Device Have Outcomes Similar to Younger Patients

HAWLEY H. SEILER RESIDENT AWARD PAPER The Hawley H. Seiler Resident Award is presented annually to the resident with the oral presentation and manuscript deemed the best of those submitted for the competition.

Novel Devices for End-Stage Heart Failure

Novel Devices for End-Stage Heart Failure Lynne Warner Stevenson No conflicts of interest Off-label assist devices and expanded indications will be discussed Devices for End-Stage Heart Failure New definitions

Perioperative Management of the Mechanical Circulatory Support Patient. American Association of Thoracic Surgeons Allied Health Symposium May 4, 2013

Perioperative Management of the Mechanical Circulatory Support Patient American Association of Thoracic Surgeons Allied Health Symposium May 4, 2013 Disclosures None 2012 MFMER slide-2 Objectives Review

MEMBERSHIP NEWSLETTER Volume 2, Spring Issue

MEMBERSHIP NEWSLETTER Volume 2, Spring Issue 2016 A message from Intermacs Principal Investigator Greetings from Intermacs, Again the registry finds itself in the middle of a very busy period. On March

Regional Differences in Utilization and Outcomes of Left Ventricular Assist Devices: Insights from the INTERMACS Registry

Regional Differences in Utilization and Outcomes of Left Ventricular Assist Devices: Insights from the INTERMACS Registry Selim Krim, MD 1 ; Rey Vivo, MD 2 ; Patrick Campbell, MD 1 ; Jerry Estep, MD 3

Jennifer A. Brown The Cleveland Clinic School of Perfusion Cleveland, Ohio

Biventricular Heart Failure Advanced Treatment Options at The Cleveland Clinic Jennifer A. Brown The Cleveland Clinic School of Perfusion Cleveland, Ohio I have no disclosures. Examine respiratory and

Outpatient Treatment of MCS Patient. F. Bennett Pearce, MD Professor of Pediatrics Med Director Heart Transplant COA

Outpatient Treatment of MCS Patient F. Bennett Pearce, MD Professor of Pediatrics Med Director Heart Transplant COA Disclosure Statement I DO NOT HAVE ANY RELEVANT FINANCIAL RELATIONSHIPS WITH ANY COMMERCIAL

Age and Outcome After Continuous-Flow Left Ventricular Assist Device Implantation as Bridge to Transplantation

Age and Outcome After Continuous-Flow Left Ventricular Assist Device Implantation as Bridge to Transplantation Sigrid E. Sandner, MD, a Daniel Zimpfer, MD, a Philipp Zrunek, a Angela Rajek, MD, b Heinrich

Should Heart Transplant Recipients With Early Graft Failure Be Considered for Retransplantation?

Should Heart Transplant Recipients With Early Graft Failure Be Considered for Retransplantation? ADULT CARDIAC Alexander Iribarne, MD, MS, Kimberly N. Hong, MHSA, Rachel Easterwood, BA, Jonathan Yang,

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C. McCants, MD, Sumanth D. Prabhu, MD, Emma J. Birks,

The Future Direction of the Adult Heart Allocation System in the United States

American Journal of Transplantation 2015; 15: 44 54 Wiley Periodicals Inc. Special Article C Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons doi:

Further devices to treat heart failure

Postgraduate Course Heart Failure Further devices to treat heart failure Pr. Matthias Kirsch Department of Cardiac Surgery Centre Hospitalo-Universitaire Vaudois Université de Lausanne e-mail: matthias.kirsch@chuv.ch

None. Declaration of conflict of interest

None Declaration of conflict of interest New Long Term Circulatory Support Technology and Treatment Strategies Stephen Westaby Oxford, UK Cardiac Transplantation: Facts from the UNOS Database Median survival

Krabatsch et al. Journal of Cardiothoracic Surgery (2017) 12:23 DOI /s

Krabatsch et al. Journal of Cardiothoracic Surgery (2017) 12:23 DOI 10.1186/s13019-017-0587-3 RESEARCH ARTICLE Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment

Mechanical Circulatory Support for the Failing Heart Progress, Pitfalls and Promises

Heart, Lung and Circulation (2015) 24, 527 531 1443-9506/04/$36.00 http://dx.doi.org/10.1016/j.hlc.2015.02.004 EDITORIAL Mechanical Circulatory Support for the Failing Heart Progress, Pitfalls and Promises